Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...
Journal of Nuclear Medicine March 2025, jnumed.124.268943; DOI: https://doi.org/10.2967/jnumed.124.268943 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269005; DOI: https://doi.org/10.2967/jnumed.124.269005 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269357; DOI: https://doi.org/10.2967/jnumed.124.269357 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268586; DOI: https://doi.org/10.2967/jnumed.124.268586 ...
Journal of Nuclear Medicine March 2025, jnumed.124.268872; DOI: https://doi.org/10.2967/jnumed.124.268872 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268496; DOI: https://doi.org/10.2967/jnumed.124.268496 This paper aims to develop and evaluate the potential of ...
Journal of Nuclear Medicine March 2025, jnumed.124.268035; DOI: https://doi.org/10.2967/jnumed.124.268035 You do not have access to the full text of this article, the ...
Radiopharmaceutical therapies (RPTs) are oncologic treatments that deliver radiation directly to cancer cells. Over the last decade, RPTs have shown great promise in managing neuroendocrine tumors (1) ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine March 2025, jnumed.124.269175; DOI: https://doi.org/10.2967/jnumed.124.269175 ...
Differences in Fibroinflammatory Activity Shown on 68 Ga-FAPI-04 and 18 F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease ...